Literature DB >> 19049767

Ablation of ganglionic plexi during combined surgery for atrial fibrillation.

Nicolas Doll1, Patrick Pritzwald-Stegmann, Markus Czesla, Joerg Kempfert, Monika Anna Stenzel, Michael A Borger, Friedrich-Wilhelm Mohr.   

Abstract

PURPOSE: Recent investigations into the treatment of atrial fibrillation have suggested improved outcomes after concomitant pulmonary vein isolation (PVI) and ganglionic plexi (GP) ablation. We investigated the impact of left atrial ablation with substrate modification (left atrial maze) or epicardial PVI, combined with GP mapping and ablation, in patients with paroxysmal or longstanding persistent atrial fibrillation undergoing additional off-pump or on-pump cardiac surgery. DESCRIPTION: Twelve patients aged 74.9 +/- 3.8 years, with atrial fibrillation for 4.5 +/- 1.5 years, underwent left atrial maze or epicardial PVI, along with GP mapping and ablation during coronary bypass grafting with or without valve surgery. The GP mapping used high-frequency bipolar stimulation. The GP ablation and PVI were achieved using bipolar radiofrequency ablation. Conduction block was confirmed by pacing. EVALUATION: At 1-year follow-up, 83% of patients were in sinus rhythm. Echocardiography confirmed satisfactory bi-atrial contraction. Exercise-induced heart rate variability was appropriate. There were no early deaths.
CONCLUSIONS: Epicardial PVI, left atrial maze, GP mapping, and ablation for the treatment of atrial fibrillation can be effectively and safely performed during surgery for other cardiac pathologies.

Entities:  

Mesh:

Year:  2008        PMID: 19049767     DOI: 10.1016/j.athoracsur.2008.06.077

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

Review 1.  Surgery for atrial fibrillation.

Authors:  Richard Lee; Jane Kruse; Patrick M McCarthy
Journal:  Nat Rev Cardiol       Date:  2009-08       Impact factor: 32.419

Review 2.  Non-pharmacological, non-ablative approaches for the treatment of atrial fibrillation: experimental evidence and potential clinical implications.

Authors:  Benjamin J Scherlag; Hiroshi Nakagawa; Warren M Jackman; Ralph Lazzara; Sunny S Po
Journal:  J Cardiovasc Transl Res       Date:  2010-11-06       Impact factor: 4.132

Review 3.  The Autonomic Nervous System and Atrial Fibrillation:The Roles of Pulmonary Vein Isolation and Ganglionated Plexi Ablation.

Authors:  Benjamin J Scherlag; Hiroshi Nakagawa; Eugene Patterson; Warren M Jackman; Ralph Lazzara; Sunny S Po
Journal:  J Atr Fibrillation       Date:  2009-08-01

4.  Outflow tract premature ventricular depolarizations after atrial fibrillation ablation may reflect autonomic influences.

Authors:  Parin J Patel; Lisa Ahlemeyer; Melanie Freas; Joshua M Cooper; Francis E Marchlinski; David J Callans; Mathew D Hutchinson
Journal:  J Interv Card Electrophysiol       Date:  2014-06-14       Impact factor: 1.900

5.  Autonomic denervation for the treatment of atrial fibrillation.

Authors:  Demosthenes G Katritsis
Journal:  Indian Pacing Electrophysiol J       Date:  2011-11-15

Review 6.  The surgical treatment of atrial fibrillation.

Authors:  Anson M Lee; Spencer J Melby; Ralph J Damiano
Journal:  Surg Clin North Am       Date:  2009-08       Impact factor: 2.741

Review 7.  Elimination Of Triggers Without An Additional Substrate Modification Is Not Sufficient In Patients With Persistent Atrial Fibrillation.

Authors:  Junbeom Park; Hui-Nam Pak
Journal:  J Atr Fibrillation       Date:  2015-02-28

8.  Cardiac Autonomic Denervation for Ablation of Atrial Fibrillation.

Authors:  George D Katritsis; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2014-08-30

9.  Towards personalized clinical in-silico modeling of atrial anatomy and electrophysiology.

Authors:  Martin W Krueger; Walther H W Schulze; Kawal S Rhode; Reza Razavi; Gunnar Seemann; Olaf Dössel
Journal:  Med Biol Eng Comput       Date:  2012-10-16       Impact factor: 2.602

Review 10.  Neuroscientific therapies for atrial fibrillation.

Authors:  Peter Hanna; Eric Buch; Stavros Stavrakis; Christian Meyer; John D Tompkins; Jeffrey L Ardell; Kalyanam Shivkumar
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.